本コンテンツは、医療従事者にとって有用な学術情報をお届けすることを目的としており、
公平な立場から一定のキーワードを元に選択した高尿酸血症や痛風に関する記事をお届けしています。
一部、国内での承認外の情報が含まれることもありますが、これを推奨するものではありません。
また、特定の薬剤の処方誘引あるいは企業の営利を企図するものではありません。
治療、各薬剤の使用にあたっては最新の製品添付文書をご参照ください。
論文タイトルを押すとPubmedもしくは医中誌Webへ移動します。
※なお、医中誌Web利用には会員登録が必要になります。
2024.08.05
-
日本小児科学会雑誌(0001-6543)128巻4号 Page635(2024.04)
2024/5/1
医中誌文献番号:Y502450120
高尿酸血症治療薬アロプリノール服用により運動後急性腎障害予防が可能であった腎性低尿酸血症1型の男児例福島 崇彰(十和田市立中央病院 小児科), 鎌田 槙, 小田 誠, 津川 浩二, 松尾 洋孝
-
アニムス(1342-0119)29巻2号 Page23-28(2024.04)
2024/5/1
医中誌文献番号:2024161408
【慢性腎臓病の治療戦略】慢性腎臓病薬物治療の現状松本 有里子(久留米大学 医学部内科学講座腎臓内科部門), 深水 圭
-
Technol Health Care. 2024 Jun 3. doi: 10.3233/THC-232028. Online ahead of print.
2024/6/14
Correlation between serum uric acid level and atrial fibrillation in patients with hyperthyroidism on medical data analysis context of IoT
Chen P, Wang X, Yan P, Jiang C, Lei Y, Miao Y.
-
Clin Cardiol. 2024 Jun;47(6):e24297. doi: 10.1002/clc.24297.
2024/6/14
Urate-lowering therapy in patients with hyperuricemia and heart failure: A retrospective cohort study using the UK Clinical Practice Research Datalink
Kiddle SJ, Sundell KA, Perl S, Nolan S, Bjursell M.
-
Int J Rheum Dis. 2024 Jun;27(6):e15205. doi: 10.1111/1756-185X.15205.
2024/6/14
Establishment and validation of prediction model for atherosclerotic cardiovascular disease in patients with hyperuricemia
Du X, Chen F, He Y, Zou H, Pan H, Zhu X.
-
Front Med (Lausanne). 2024 May 30;11:1343000. doi: 10.3389/fmed.2024.1343000. eCollection 2024.
2024/6/14
Prevalence and risk factors for hyperuricemia and hyperuricosuria in patients with hematologic malignancies
Kunlayawutipong T, Rattanathammethee T, Punnachet T, Hantrakun N, Piriyakhuntorn P, Hantrakool S, Chai-Adisaksopha C, Rattarittamrong E, Tantiworawit A, Norasetthada L, Louthrenoo W.
-
Clin Case Rep. 2024 Jun 11;12(6):e9033. doi: 10.1002/ccr3.9033. eCollection 2024 Jun.
2024/6/13
Tophaceous gout
Neupane D, Lageju N, Jaiswal LS, Pandit N, Mahat A, Ghimire S, Pokhrel U, Koirala S.
-
Chem Biodivers. 2024 Jun 12:e202400865. doi: 10.1002/cbdv.202400865. Online ahead of print.
2024/6/13
Phytochemical analysis, and antioxidant and hepatoprotective activities of Chamaerops humilis L. leaves; a focus on xanthine oxidase
Ahmed SA, Kamel EM, Mahmoud AM, Nasr HMD, Hassan HM, Alanazi MM, Rateb ME, Hozayen WG, Ahmed SA.
-
Nat Commun. 2024 Jun 12;15(1):5039. doi: 10.1038/s41467-024-49420-9.
2024/6/13
Structural basis for urate recognition and apigenin inhibition of human GLUT9
Shen Z, Xu L, Wu T, Wang H, Wang Q, Ge X, Kong F, Huang G, Pan X.
-
PLoS One. 2024 Jun 12;19(6):e0305100. doi: 10.1371/journal.pone.0305100. eCollection 2024.
2024/6/12
Prognostic model of in-hospital ischemic stroke mortality based on an electronic health record cohort in Indonesia
Yamanie N, Felistia Y, Susanto NH, Lamuri A, Sjaaf AC, Miftahussurur M, Santoso A.
-
Med Sci Monit. 2024 Jun 12;30:e944314. doi: 10.12659/MSM.944314.
2024/6/12
Comparative Cardiovascular Risks of Febuxostat and Allopurinol in Patients with Diabetes Mellitus and Chronic Kidney Disease
Huang HH, Chen YY, Fang YW, Liou HH, Wang JT, Tsai MH.
-
Tunis Med. 2024 Jun 5;102(6):348-353. doi: 10.62438/tunismed.v102i6.4884.
2024/6/12
Physical activity assessment in rheumatoid arthritis: a 120-patient cross-sectional study
Ben Tekaya A, Rouached L, Ben Dhia S, Bouden S, Tekaya R, Mahmoud I, Saidane O, Abdelmoula L.
-
Poult Sci. 2024 May 22;103(8):103887. doi: 10.1016/j.psj.2024.103887. Online ahead of print.
2024/6/12
Effects of Smilax China L. extracts on Hyperuricemia chicken model via inhibiting xanthine oxidase activity
Yan M, Zheng X, Lin Y, Zheng X, Xi K, Gao Y, Wang H, Li Y, Liu C.
-
PLoS One. 2024 Jun 11;19(6):e0304105. doi: 10.1371/journal.pone.0304105. eCollection 2024.
2024/6/11
Association of urinary excretion rates of uric acid with biomarkers of kidney injury in patients with advanced chronic kidney disease
López Iglesias A, Blanco Pardo M, Rodríguez Magariños C, Pértega S, Sierra Castro D, García Falcón T, Rodríguez-Carmona A, Pérez Fontán M.
-
Dokl Biochem Biophys. 2024 Jun 10. doi: 10.1134/S1607672924700881. Online ahead of print.
2024/6/11
Diastolic Dysfunction of the Left and Right Ventricles in Patients with Calcium Pyrophosphate Crystal Storage Disease and Osteoarthritis
Eliseev MS, Zhelyabina OV, Kirillova IG, Korsakova YO, Cheremushkina EV.
-
Int J Nanomedicine. 2024 Jun 6;19:5297-5316. doi: 10.2147/IJN.S464994. eCollection 2024.
2024/6/11
Supersaturated Drug Delivery System of Oxyberberine Based on Cyclodextrin Nanoaggregates: Preparation, Characterization, and in vivo Application
Huang Z, Zhang S, Qin Z, Ai G, Li M, Gong S, Liu Y, Zeng H, Chen J, Su Z, Lai Z.
-
Int J Nanomedicine. 2024 Jun 4;19:5139-5156. doi: 10.2147/IJN.S464948. eCollection 2024.
2024/6/11
Combined Hydroxyethyl Starch Luteolin Nanocrystals for Effective Anti-Hyperuricemia Effect in Mice Model
Luo H, Wang X, Fang M, Yu H, Gui L, Wu Z, Sheng J, Li F.
-
Eur J Med Res. 2024 Jun 10;29(1):320. doi: 10.1186/s40001-024-01923-3.
2024/6/11
Association of C-reactive protein with all-cause and cause-specific mortality in people with gout
Han L, Zhang L, Hu W, Lu Y, Wang Z.
-
J Cardiovasc Transl Res. 2024 Jun 10. doi: 10.1007/s12265-024-10526-6. Online ahead of print.
2024/6/10
CRISPR/Cas9 Mediated Deletion of the Uox Gene Generates a Mouse Model of Hyperuricemia with Multiple Complications
Zeng L, Shali S, Gao Y, Du X, Zhu X, Li L, Dai Y, Zhou P.
-
Cureus. 2024 May 8;16(5):e59934. doi: 10.7759/cureus.59934. eCollection 2024 May.
2024/6/10
Exploring Multifactorial Relationships: Assessing the Correlation Between Cardiovascular Health Indicators and Metabolic Markers
Shende S, Rathored J, Barole N.
-
J Ethnopharmacol. 2024 Jun 5;333:118410. doi: 10.1016/j.jep.2024.118410. Online ahead of print.
2024/6/8
Elucidating the substance basis and pharmacological mechanism of Fufang Qiling granules in modulating xanthine oxidase for intervention in hyperuricemia
Ye J, Yao J, Xu S, Xiao G, Jia Y, Xie N, Yan J, Ying X, Zhang H.
-
Toxicol Mech Methods. 2024 Jun 10:1-12. doi: 10.1080/15376516.2024.2364191. Online ahead of print.
2024/6/7
Neuroprotective effect of marrubiin against MPTP-induced experimental Parkinson's disease in male wistar rats
Xu X, Li J, Liu M, Zhang B.
-
Pediatr Nephrol. 2024 Jun 6. doi: 10.1007/s00467-024-06413-6. Online ahead of print.
2024/6/6
Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: a case series
Goswami S, Hanson AE, Rajadhyaksha E, Dangle PP, Schwaderer AL.
-
Kardiologiia. 2024 May 31;64(5):3-10. doi: 10.18087/cardio.2024.5.n2626.
2024/6/6
WNT Signaling Cascade Proteins and LRP6 in the Formation of Various Types of Coronary Lesions in Patients With Coronary Artery Disease
Belenkov YN, Iusupova AO, Slepova OA, Pakhtusov NN, Popova LV, Lishuta AS, Krivova AV, Khabarova NV, Abidaev MY, Privalova EV.
-
Front Endocrinol (Lausanne). 2024 May 22;15:1367621. doi: 10.3389/fendo.2024.1367621. eCollection 2024.
2024/6/6
Diastolic and systolic blood pressure and gout: a Mendelian randomization study
Li Y, Xie Y, Li J, Chang Z, Zhang J, Zhou Z, Ren R, Chen Y.
-
Sci Rep. 2024 Jun 5;14(1):12968. doi: 10.1038/s41598-024-63340-0.
2024/6/6
Association between uric acid and referable diabetic retinopathy in patients with type 2 diabetes
Rivera-De-la-Parra D, Hernández-Jiménez S, Almeda-Valdés P, Aguilar-Salinas CA, Graue-Hernández EO, Pérez-Peralta L, Jiménez-Corona A; Group of Study CAIPaDi.
-
Fitoterapia. 2024 Jun 3;177:106050. doi: 10.1016/j.fitote.2024.106050. Online ahead of print.
2024/6/6
Benzyl-isoquinoline alkaloids rich extract of Coptis teeta Wall., exhibit potential efficacy in calcium-oxalate and uric-acid linked metabolic disorders
Misra A, Chaudhary MK, Rawat P, Tripathi D, Barik SK, Srivastava S.
-
Rheumatol Ther. 2024 Jun 5. doi: 10.1007/s40744-024-00681-2. Online ahead of print.
2024/6/5
Projected Health and Economic Burden of Comorbid Gout and Chronic Kidney Disease in a Virtual US Population: A Microsimulation Study
Card-Gowers J, Retat L, Kumar A, Marder BA, Padnick-Silver L, LaMoreaux B, Webber L.
-
Altern Ther Health Med. 2024 Jun 5:AT10457. Online ahead of print.
2024/6/5
Accelerated Fibrosis Progression of Diabetic Nephropathy From High Uric Acid's Activation of the ROS/NLRP3/SHP2 Pathway in Renal Tubular Epithelial Cells Under High Glucose Conditions
Tian L, Yu Q, Zhang L, Zhang J.
-
Sci Rep. 2024 Jun 4;14(1):12765. doi: 10.1038/s41598-024-63594-8.
2024/6/5
Risk factors for bloodstream infection among patients admitted to an intensive care unit of a tertiary hospital of Shanghai, China
Cui Y, Yi C, Zhang C, Yang C, Wang X, Chen W, Peng Y, Dai J.
-
Arthritis Care Res (Hoboken). 2024 Jun 3. doi: 10.1002/acr.25380. Online ahead of print.
2024/6/4
Adherence and Treat-to-Target Benchmarks in Older Adults With Gout Initiating Urate-Lowering Therapy in Ontario, Canada: A Population-Based Study
Kwok TSH, Kuriya B, Hawker G, Eder L, Li P, Choy G, Widdifield J.
-
Cell Biochem Biophys. 2024 Jun 3. doi: 10.1007/s12013-024-01313-w. Online ahead of print.
2024/6/4
Synergistic Effects of Vitamin D and Exercise on Diabetes-induced Gonadotoxicity in Male Wistar Rats: Role of Xanthine Oxidase/Uric Acid and Nrf2/NfkB Signaling
Odetayo AF, Abdulrahim HA, Fabiyi OT, Adewole TA, Ajiboye BE, Omeiza AN, Olayaki LA.
-
J Food Sci. 2024 Jun 3. doi: 10.1111/1750-3841.17144. Online ahead of print.
2024/6/3
Identification and molecular docking of xanthine oxidase and α-glucosidase inhibitors in Opuntia ficus-indica fruit
Wang H, Zhou X, Liu Y, Xie W, Yang D, Huo D, Guo Q, Wang R.
-
Br J Nutr. 2024 Jun 3:1-29. doi: 10.1017/S0007114524001211. Online ahead of print.
2024/6/3
The Ameliorative and Neuroprotective Effects of Dietary Fiber on Hyperuricemia mice:A perspective from Microbiome and Metabolome
Wang Y, Miao F, Wang J, Zheng M, Yu F, Yi Y.
-
Niger Postgrad Med J. 2024 Apr 1;31(2):139-146. doi: 10.4103/npmj.npmj_54_24. Epub 2024 Jun 3.
2024/6/3
Cardiovascular Risk Awareness, Exercise Practices and Metabolic Outcomes among Patients with Diabetes Mellitus in Northern Nigeria: A Cross-sectional, Multicentre Study
Alkali NH, Uloko AE, Chiroma I, Mugana A, Garba MA, Okpe IO, Gargah ET, Abdullahi UF, Shadrach L, Haladu IA.
-
Yakugaku Zasshi. 2024;144(6):659-674. doi: 10.1248/yakushi.23-00217.
2024/6/3
[Uric Acid Metabolism, Uric Acid Transporters and Dysuricemia]
Ichida K.
-
Dig Liver Dis. 2024 Jun 1:S1590-8658(24)00773-4. doi: 10.1016/j.dld.2024.05.015. Online ahead of print.
2024/6/3
Metabolic signatures of metabolic dysfunction-associated steatotic liver disease in severely obese patients
Babu AF, Palomurto S, Kärjä V, Käkelä P, Lehtonen M, Hanhineva K, Pihlajamäki J, Männistö V.
-
Phytochemistry. 2024 Aug;224:114169. doi: 10.1016/j.phytochem.2024.114169. Epub 2024 May 31.
2024/6/3
Glucoconjugated monoterpene indole alkaloids with xanthine oxidase inhibitory activity from Ophiorrhiza japonica
Shi BB, Xu F, Zhang GR, He Y, Liu Q, Feng ML, Li ZH, Liu JK.
-
Chem Biol Interact. 2024 Jul 1;397:111087. doi: 10.1016/j.cbi.2024.111087. Epub 2024 May 31.
2024/6/2
Exploring Asphodelus microcarpus as a source of xanthine oxidase inhibitors: Insights from in silico and in vitro studies
Di Petrillo A, Siguri C, Delogu GL, Fais A, Era B, Floris S, Pintus F, Kumar A, Fantini MC, Olla S.
-
Iran J Allergy Asthma Immunol. 2024 Apr 7;23(2):168-181. doi: 10.18502/ijaai.v23i2.15323.
2024/6/1
Trial of Cardiovascular Risk Factor Assessment and Transthoracic Echocardiography Results in Patients with Primary Antibody Deficiency
Napiórkowska-Baran K, Grześk G, Błażejewski J, Ziętkiewicz M, Więsik-Szewczyk E, Matyja-Bednarczyk A, Tykwińska M, Grześk E, Lubański J, Schmidt O, Szymczak B, Zacniewski R, Szynkiewicz E, Owsiany M, Bartuzi Z.
-
BMC Neurol. 2024 May 31;24(1):183. doi: 10.1186/s12883-024-03628-w.
2024/6/1
The prognostic value of combined uric acid and neutrophil-to-lymphocyte ratio in acute ischemic stroke patients treated with intravenous thrombolysis
Wang C, Zhou M, Kang T, You S, Cao Y, Kong W, Shi J.